Feasibility of vitamin D supplementation interventions to mitigate HIV pre-exposure prophylaxis-related bone mineral density loss: a cross-sectional survey

BACKGROUND: Daily tenofovir disoproxil fumarate (TDF)/emtricitabine as HIV pre-exposure prophylaxis (PrEP) causes subclinical decreases in bone mineral density (BMD). We surveyed PrEP users to assess feasibility for a clinical trial of vitamin D supplementation to mitigate TDF-induced BMD loss. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shaoyuan, Kortenaar, Jean-Luc, Hull, Mark W, Arbess, Gordon, Owen, James RM, Tan, Darrell HS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199226/
https://www.ncbi.nlm.nih.gov/pubmed/30410315
http://dx.doi.org/10.2147/PPA.S178403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199226/
https://www.ncbi.nlm.nih.gov/pubmed/30410315
http://dx.doi.org/10.2147/PPA.S178403

Ejemplares similares